Introduction The hemp industry’s long-anticipated move into healthcare-adjacent distribution just took a major concrete step. Cornbread Hemp has secured an exclusive contract with Alliant Purchasing — a group purchasing organization (GPO) that serves 68,000 healthcare locations affiliated with Medicare programs — to supply USDA organic hemp-derived CBD products beginning April...

Introduction The map of state-level hemp restrictions keeps expanding. Pennsylvania and Rhode Island have joined Ohio, Missouri, Texas, and others in moving to tighten restrictions on hemp-derived products — part of a nationwide trend of states aligning with or accelerating past the November 12, 2026 federal compliance deadline. For B2B...

Introduction The US Hemp Roundtable — one of the industry’s leading advocacy organizations — has put a number on the scope of the November 12, 2026 compliance cliff: 95%. That’s the estimated share of currently available hemp products that will not meet the new federal standard and will be prohibited...

Hemp Import Tariffs Are Pushing Brands Toward Domestic Sourcing Meta Title: Hemp Import Tariffs Are Pushing Brands Toward Domestic Sourcing — What B2B Buyers Need to Know Meta Description: New tariffs on imported hemp biomass are reshaping the B2B hemp supply chain, accelerating the shift toward domestic cultivation and extraction....

Introduction The dominoes are falling. On April 2, 2026, the Missouri legislature passed a bill that effectively bans the sale of intoxicating hemp-derived products — THC seltzers, hemp-derived edibles, and similar goods — from general retail channels. The bill passed the House 126–23 and cleared the Senate before heading to...

Introduction As the November 12, 2026 federal hemp compliance deadline looms, a growing coalition of bipartisan lawmakers is pushing back — filing legislation that would extend the deadline by two full years, to November 2028. Multiple bills have been introduced in both chambers, with supporters arguing that the industry needs...

Introduction When Congress passed the 2025 Continuing Resolution and rewrote the federal definition of hemp, it came with a built-in requirement for the FDA: within 90 days of enactment, the agency was mandated to publish three specific lists — naturally occurring cannabinoids, THC-class cannabinoids, and all known cannabinoids with THC-like...

Introduction Amid the wave of state bans and federal compliance deadlines dominating hemp industry news, a quietly significant development is emerging from the Centers for Medicare & Medicaid Services (CMS). Reports indicate that CMS is developing a model that could allow eligible Medicare beneficiaries to receive limited annual access —...

Introduction The 2026 Farm Bill has been one of the most closely watched legislative vehicles in the hemp industry — with widespread speculation that it could serve as a pathway to modify, delay, or clarify the November 12, 2026 compliance deadline. But as the bill advances through Congress in early...

Introduction When Senators Ron Wyden and Jeff Merkley of Oregon reintroduced the Cannabinoid Safety and Regulation Act (CSRA) in December 2025, they offered the hemp industry something it had been asking for since 2018: a federal regulatory framework for hemp-derived cannabinoids that treats them like the consumer products they are...

Introduction Buried in the November 2025 legislation that redefined hemp and set the November 12, 2026 product deadline is a requirement that has received far less industry attention than it deserves: the FDA has 90 days from enactment to publish three specific lists of cannabinoids. Those three lists — of...

Introduction The hemp beverage market is in the middle of a consolidation wave, and the M&A activity is an early indicator of how the broader hemp industry will restructure around the November 12, 2026 compliance deadline. Agrify Corporation's acquisition of assets from Double or Nothing LLC — the owner of...

Introduction For most of hemp's commercial history, CBD was the entire conversation. Then CBG entered the mainstream. Now the minor cannabinoids — CBN, CBC, CBDV, and others — are moving from research abstracts into active B2B ingredient sourcing conversations. This shift is being driven by two forces: consumer demand for...

The U.S. Hemp Roundtable has put a number to the scale of what November 12, 2026 represents for the hemp industry: approximately 300,000 jobs and over $1.5 billion in aggregate state tax revenue are at risk from the federal restrictions on hemp-derived cannabinoid products. Those numbers reflect the estimated employment...

Hemp businesses have always had a complicated relationship with banking. Even after the 2018 Farm Bill federally legalized hemp, many financial institutions remained reluctant to serve the industry — citing regulatory uncertainty, compliance risk, and the difficulty of distinguishing lawful hemp products from illegal cannabis. As November 12, 2026 approaches,...

Introduction When the US Hemp Roundtable estimates that 95% of current hemp products won’t survive the November 12, 2026 federal compliance deadline, the immediate reaction from most of the industry is alarm. Understandably. But for the brands already operating in the compliant 5% — or actively building toward it —...

The House Agriculture Committee voted 34-17 on March 5 to advance the Farm, Food, and National Security Act of 2026. For the hemp industry, which has been hoping the Farm Bill would be a vehicle to delay or modify the November 12, 2026 intoxicating hemp ban, the result was decisive:...

Ohio's Hemp Ban Took Effect — Here's What B2B Operators Should Learn From It Ohio became a live preview of November 12, 2026 on March 20. That's when Senate Bill 56 took effect, banning the sale of intoxicating hemp products — delta-8 THC beverages, THC-infused gummies, hemp-derived intoxicants of any...